EPHX2 and metabolic dysfunction-associated steatohepatitis: In addition to increased sEH activity converting protective EETs into inflammatory DHETs, which worsens inflammation in NASH, elevated 15-LO activity enhances 15-HETE production in some NASH patients (10, 38) further exacerbating liver inflammation and disease progression.